People news

Share this article:

Peregrine Pharmaceuticals, a clinical stage biopharmaceutical company developing monoclonal antibodies for the treatment of cancer and hepatitis C virus infection, appointed Mary Boyd as head of business development for Asia and Europe. Boyd has more than 20 years of international pharmaceutical and biotechnology business development experience with large pharmaceutical companies including GlaxoSmithKline, Novartis and Roche. She will focus on identifying potential partners and negotiating agreements for Peregrine's extensive clinical and preclinical assets in Asian and European markets.

has promoted Sally Shankland to CEO of CMPMedica US. Shankland served as SVP of CMPMedica's US promotional business unit for six years prior to accepting the promotion. She has worked for United Business Media companies since 1988, when she began working for Miller Freeman. Shankland replaces Vicki Masseria, who spent 26 years working at CMPMedica and its predecessor companies.

Clark Kokich
has been promoted to CEO of interactive agency Avenue A | Razorfish. Kokich previously held the title of worldwide president for the past two years.

Share this article:
You must be a registered member of MMM to post a comment.

Next Article in People Moves

Email Newsletters


Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in People Moves

Monday Moves: October 20

Promotions and hires for agencies and manufacturers

Monday Moves: September 29

Promotions and hires for agencies and manufacturers

Monday Moves—July 21, 2014

Hires and promotions for Manufacturers, Agencies and Media